Sanofi, 10% Owner at Fulcrum Therapeutics, Inc. (FULC), bought 558,035 shares at $16.00 ($1.5M) on 2019-07-22, disclosed to the SEC on 2019-07-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 464,285 | $0 | 0.0% |
| 2 | $16.00 | 93,750 | $1.5M | 100.0% |
| Total | $2.69 avg | 558,035 | $1.5M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |